4-(1-Fmoc-Piperidin-4-yl)-butyric acid, 97.0%, 100mg

(3S,5S)-(5-Methyl-pyrrolidin-3-yl)-carbamic acid tert-butyl ester, 97%, 250mg

Thalidomide-propargyl, 10mg

tert-Butyl N-[2-(2-bromophenyl)propan-2-yl]carbamate, 1g

2-(2,6-Dioxopiperidin-3-yl)-1-oxoisoindoline-5-carbaldehyde, 98%, 1g

3-(3-bromophenyl)-2-hydroxyprop-2-enoic acid, 95%, 2.5g

2-(2-Methylimidazol-1-yl)benzaldehyde, 95.0%, 1g

1-isopropyl-1H-pyrazole-3-carbonyl chloride, 95.0%, 250mg

Dialysis membrane Spectra/Por® Biotech CE MWCO 8000–10,000, 16 mm, 1 Piece(s)

3-METHYL-1H,2H,3H-PYRROLO[2,3-B]PYRIDIN-2-ONE, 95.0%, 1g

2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium Chloride>98.0%(HPLC)(T)5g

5-(Benzyloxy)pyridine-2-carboxylic acid, 95%, 500mg

6-Chloro-2,3-dimethylpyridine, 95.0%, 1g